Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

313 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tuberculosis, one disease, many faces.
Migliori GB, Centis R, Lange C, Matteelli A, Cirillo D. Migliori GB, et al. Among authors: matteelli a. Monaldi Arch Chest Dis. 2008 Mar;69(1):2-4. doi: 10.4081/monaldi.2008.404. Monaldi Arch Chest Dis. 2008. PMID: 18507192 No abstract available.
Prevalence of resistance to anti-tuberculosis drugs: results of the 1998/99 national survey in Italy.
Migliori GB, Fattorini L, Vaccarino P, Besozzi G, Saltini C, Orefici G, Iona E, Matteelli A, Fiorentini F, Codecasa LR, Casali L, Cassone A; SMIRA (Italian Multicentre Study on Resistance to Anti-tuberculosis drugs) Study Group. Migliori GB, et al. Among authors: matteelli a. Int J Tuberc Lung Dis. 2002 Jan;6(1):32-8. Int J Tuberc Lung Dis. 2002. PMID: 11931399
Clinical and operational value of the extensively drug-resistant tuberculosis definition.
Migliori GB, Besozzi G, Girardi E, Kliiman K, Lange C, Toungoussova OS, Ferrara G, Cirillo DM, Gori A, Matteelli A, Spanevello A, Codecasa LR, Raviglione MC; SMIRA/TBNET Study Group. Migliori GB, et al. Among authors: matteelli a. Eur Respir J. 2007 Oct;30(4):623-6. doi: 10.1183/09031936.00077307. Epub 2007 Aug 9. Eur Respir J. 2007. PMID: 17690121 Free article.
Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results.
Migliori GB, Lange C, Girardi E, Centis R, Besozzi G, Kliiman K, Ortmann J, Matteelli A, Spanevello A, Cirillo DM; SMIRA/TBNET Study Group. Migliori GB, et al. Among authors: matteelli a. Clin Infect Dis. 2008 Mar 15;46(6):958-9. doi: 10.1086/528875. Clin Infect Dis. 2008. PMID: 18288911 Free article. No abstract available.
High risk of tuberculosis in health care workers in Romania.
Sotgiu G, Arbore AS, Cojocariu V, Piana A, Ferrara G, Cirillo DM, Matteelli A, Castiglia P, Ditiu L, Spanevello A, Zellweger JP, Mihaescu T, Migliori GB. Sotgiu G, et al. Among authors: matteelli a. Int J Tuberc Lung Dis. 2008 Jun;12(6):606-11. Int J Tuberc Lung Dis. 2008. PMID: 18492325
Epidemiology and clinical management of XDR-TB: a systematic review by TBNET.
Sotgiu G, Ferrara G, Matteelli A, Richardson MD, Centis R, Ruesch-Gerdes S, Toungoussova O, Zellweger JP, Spanevello A, Cirillo D, Lange C, Migliori GB. Sotgiu G, et al. Among authors: matteelli a. Eur Respir J. 2009 Apr;33(4):871-81. doi: 10.1183/09031936.00168008. Epub 2009 Feb 27. Eur Respir J. 2009. PMID: 19251779 Free article. Review.
Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
Sotgiu G, Lange C, Richardson MD, Matteelli A, Centis R, Eker B, Guenther G, Spanevello A, Migliori GB; TBNET. Sotgiu G, et al. Among authors: matteelli a. J Antimicrob Chemother. 2009 Oct;64(4):879-83; author reply 883-4. doi: 10.1093/jac/dkp265. Epub 2009 Aug 3. J Antimicrob Chemother. 2009. PMID: 19651787 No abstract available.
313 results